Search

Li Y Cheng

from Columbia, MO
Age ~56
Get Report
Also known as:
Ching Yi Li, Li Yi Ching, Yuiching Li, Li Yuiching, Li Yiching, Ching Liyi, Ching Li Yi
Related to:
Chengyue Shen, 49Liming M Chou, 55Yuandi LiChanglin Liu, 69Wei Li, 52Yiqun L Li, 54
Connected to:
Adelaide M Cheng, 42Adoracion S Cheng, 79Aggie Cheng, 51Alain Cheng, 72Alex Y Cheng, 49Alexandra W Cheng, 56Alice M Cheng, 61Anderson L Cheng, 34Angelo S Cheng, 65Annie Y Cheng, 43

Li Cheng Phones & Addresses

  • Columbia, MO
  • Santa Clara, CA
  • Ashburn, VA
  • Arlington, VA
  • Simi Valley, CA

Resumes

Resumes

Li Cheng Photo 1

Jstv Advertising Sales Manager

View page
Position:
Advertising Sales Manager at JSTV, Receptionist at International House Philadelphia, Instructor at Drexel Recreation Center
Location:
Nanjing, Jiangsu, China
Industry:
Entertainment
Work:
JSTV - Nanjing, Jiangsu, China since Jun 2013
Advertising Sales Manager
International House Philadelphia since Sep 2011
Receptionist
Drexel Recreation Center since Jan 2011
Instructor
Germantown Academy - Greater Philadelphia Area Feb 2012 - Mar 2012
Accounting Consultant
Lincoln Financial Group - Greater Philadelphia Area Jan 2012 - Mar 2012
Financial Consultant
Education:
Drexel University 2010 - 2012
Master, Finance Nanjing Audit University 2006 - 2010
Bachelor, Accounting
Li Cheng Photo 2

Li Cheng

View page
Location:
United States
Li Cheng Photo 3

Li Cheng

View page
Location:
United States
Li Cheng Photo 4

Li Cheng

View page
Location:
United States
Li Cheng Photo 5

Li Cheng St. Louis, MO

View page
Work:
Wash U Joint Program

Sep 2012 to 2000
Grader & Tutor
Wash U ESE department
St. Louis, MO
Jan 2013 to May 2013
Project on Statistical Interior Tomography
Shanghai Research Institute Co., Ltd. of China Post Group

Nov 2011 to Apr 2012
Assistant Engineer (intern)
East China University of Science and Technology

Nov 2010 to Apr 2011
Builder of ticket
Education:
Washington University in St Louis
St. Louis, MO
Sep 2012 to May 2014
Master of Electrical & System Engineering
East China University of Science and Technology
Sep 2008 to Aug 2012
Bachelor of Electrical and Communication Engineering
Skills:
Programming Skills: Java(most preferred), C/C++, Python, VHDL, SQL, Assembly Language Database Development: MySQL, SQL Server Software: Eclipse, Visual Studio C++, Python, MATLAB, C++ Builder, CAD, Linux OS, Multisim 7, Quartus II, SQL Server, vision 4.0, MS OFFICE, Photoshop, maxplus II
Li Cheng Photo 6

Li Cheng San Jose, CA

View page
Work:
Tellabs Inc.
Santa Clara, CA
Oct 2012 to Feb 2013
Internship
Education:
University of Southern California
Jan 2010 to Jan 2012
Master in Electrical Engineering
Harbin Institute of Technology
Jan 2006 to Jan 2010
Bachelor in Electrical Engineering
Skills:
Java C/C++, Matlab, OpenCV, Image Processing, Compression, DSP, Computer Vision, Pattern Recognition, Image Processing, Computer Vision Algorithm Development

Business Records

Name / Title
Company / Classification
Phones & Addresses
Li C. Cheng
President
Cheng, Liu Inc
Eating Place · Caterers
5560 Santa Teresa Blvd, San Jose, CA 95123
(408) 281-8898
Li Rose Cheng
MCKINLEY REAL ESTATE, LLC
Li Rose Cheng
INTERNATIONAL RAILWAY TECHNOLOGY, LLC
Li Tian Cheng
GOLD LEUANG JEWELRY LIMITED
Li Ping Cheng
President
Matsusono Inc
1150 Paloma Ave, Burlingame, CA 94010

Publications

Us Patents

Binding Molecules Specific For Cd73 And Uses Thereof

View page
US Patent:
20200079877, Mar 12, 2020
Filed:
Nov 8, 2019
Appl. No.:
16/678165
Inventors:
- Cambridge, GB
Kris SACHSENMEIER - Gaithersburg MD, US
Erin SULT - Gaithersburg MD, US
Qihui Huang - Gaithersburg MD, US
Peter PAVLIK - Gaithersburg MD, US
Melissa DAMSCHRODER - Gaithersburg MD, US
Li CHENG - Gaithersburg MD, US
Gundo DIEDRICH - Gaithersburg MD, US
Jonathan RIOS-DORIA - Gaithersburg MD, US
Scott HAMMOND - Gaithersburg MD, US
Ralph MINTER - Cambridge, GB
Steve RUST - Cambridge, GB
Sandrine GUILLARD - Cambridge, GB
Robert HOLLINGSWORTH - Gaithersburg MD, US
Lutz JERMUTUS - Cambridge, GB
Nicholas DURHAM - Gaithersburg MD, US
Ching Ching LEOW - Gaithersburg MD, US
Mary ANTONYSAMY - Gaithersburg MD, US
James GEOGHEGAN - Gaithersburg MD, US
Xiaojun LU - Gaithersburg MD, US
Kim ROSENTHAL - Gaithersburg MD, US
International Classification:
C07K 16/40
A61K 47/68
C07K 16/28
Abstract:
The present disclosure provides anti-CD73 binding molecules, e.g., antibodies and antigen binding fragments thereof. Also provided are pharmaceutical formulations comprising the disclosed compositions, and methods for the diagnosis and treatment of diseases associated with CD73-expression, e.g., cancer. Such diseases can be treated, e.g., by direct therapy with the anti-CD73 binding molecules disclosed herein (e.g., naked antibodies or antibody-drug conjugates that bind CD73), by adjuvant therapy with other antigen-binding anticancer agents such as immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1 monoclonal antibodies), and/or by combination therapies where the anti-CD73 molecules are administered before, after, or concurrently with chemotherapy.

Binding Molecules Specific For Cd73 And Uses Thereof

View page
US Patent:
20190292274, Sep 26, 2019
Filed:
Apr 4, 2019
Appl. No.:
16/375051
Inventors:
- Cambridge MA, US
Kris SACHSENMEIER - Gaithersburg MD, US
Erin SULT - Gaithersburg MD, US
Qihui HUANG - Gaithersburg MD, US
Peter PAVLIK - Gaithersburg MD, US
Melissa DAMSCHRODER - Gaithersburg MD, US
Li CHENG - Gaithersburg MD, US
Gundo DIEDRICH - Gaithersburg MD, US
Jonathan RIOS-DORIA - Gaithersburg MD, US
Scott HAMMOND - Gaithersburg MD, US
Ralph MINTER - Cambridge, GB
Steve RUST - Cambridge, GB
Sandrine GUILLARD - Cambridge, GB
Robert HOLLINGSWORTH - Gaithersburg MD, US
Lutz JERMUTUS - Cambridge, GB
Nicholas DURHAM - Gaithersburg MD, US
Ching Ching LEOW - Gaithersburg MD, US
Mary ANTONYSAMY - Gaithersburg MD, US
James GEOGHEGAN - Gaithersburg MD, US
Xiaojun LU - Gaithersburg MD, US
Kim ROSENTHAL - Gaithersburg MD, US
International Classification:
C07K 16/40
A61K 47/68
C07K 16/28
Abstract:
The present disclosure provides anti-CD73 binding molecules, e.g., antibodies and antigen binding fragments thereof. Also provided are pharmaceutical formulations comprising the disclosed compositions, and methods for the diagnosis and treatment of diseases associated with CD73-expression, e.g., cancer. Such diseases can be treated, e.g., by direct therapy with the anti-CD73 binding molecules disclosed herein (e.g., naked antibodies or antibody-drug conjugates that bind CD73), by adjuvant therapy with other antigen-binding anticancer agents such as immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1 monoclonal antibodies), and/or by combination therapies where the anti-CD73 molecules are administered before, after, or concurrently with chemotherapy.

Binding Molecules Specific For Cd73 And Uses Thereof

View page
US Patent:
20180194858, Jul 12, 2018
Filed:
Feb 23, 2018
Appl. No.:
15/903649
Inventors:
- Cambridge, GB
Kris SACHSENMEIER - Gaithersburg MD, US
Erin SULT - Gaithersburg MD, US
Qihui Huang - Gaithersburg MD, US
Peter PAVLIK - Gaithersburg MD, US
Melissa DAMSCHRODER - Gaithersburg MD, US
Li CHENG - Gaithersburg MD, US
Gundo DIEDRICH - Gaithersburg MD, US
Jonathan RIOS-DORIA - Gaithersburg MD, US
Scott HAMMOND - Gaithersburg MD, US
Ralph MINTER - Cambridge, GB
Steve RUST - Cambridge, GB
Sandrine GUILLARD - Cambridge, GB
Robert HOLLINGSWORTH - Gaithersburg MD, US
Lutz JERMUTUS - Cambridge, GB
Nicholas DURHAM - Gaithersburg MD, US
Ching Ching LEOW - Gaithersburg MD, US
Mary ANTONYSAMY - Gaithersburg MD, US
James GEOGHEGAN - Gaithersburg MD, US
Xiaojun LU - Gaithersburg MD, US
Kim ROSENTHAL - Gaithersburg MD, US
International Classification:
C07K 16/40
A61K 47/68
C07K 16/28
A61K 39/00
Abstract:
The present disclosure provides anti-CD73 binding molecules, e.g., antibodies and antigen binding fragments thereof. Also provided are pharmaceutical formulations comprising the disclosed compositions, and methods for the diagnosis and treatment of diseases associated with CD73-expression, e.g., cancer. Such diseases can be treated, e.g., by direct therapy with the anti-CD73 binding molecules disclosed herein (e.g., naked antibodies or antibody-drug conjugates that bind CD73), by adjuvant therapy with other antigen-binding anticancer agents such as immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1 monoclonal antibodies), and/or by combination therapies where the anti-CD73 molecules are administered before, after, or concurrently with chemotherapy.

Binding Molecules Specific For Cd73 And Uses Thereof

View page
US Patent:
20160194407, Jul 7, 2016
Filed:
Nov 9, 2015
Appl. No.:
14/936233
Inventors:
- Cambridge, GB
Kris Sachsenmeier - Gaithersburg MD, US
Erin Sult - Gaithersburg MD, US
Qihui Huang - Gaithersburg MD, US
Peter Pavlik - Gaithersburg MD, US
Melissa Damschroder - Gaithersburg MD, US
Li Cheng - Gaithersburg MD, US
Gundo Diedrich - Gaithersburg MD, US
Jonathan Rios-Doria - Gaithersburg MD, US
Scott Hammond - Gaithersburg MD, US
Ralph Minter - Cambridge, GB
Steve Rust - Cambridge, GB
Sandrine Guillard - Cambridge, GB
Robert Hollingsworth - Gaithersburg MD, US
Lutz Jermutus - Cambridge, GB
Nicholas Durham - Gaithersburg MD, US
Ching Ching Leow - Gaithersburg MD, US
Mary Antonysamy - Gaithersburg MD, US
James Geoghegan - Gaithersburg MD, US
Xiaojun Lu - Gaithersburg MD, US
Kim Rosenthal - Gaithersburg MD, US
International Classification:
C07K 16/40
C07K 16/28
Abstract:
The present disclosure provides anti-CD73 binding molecules, e.g., antibodies and antigen binding fragments thereof. Also provided are pharmaceutical formulations comprising the disclosed compositions, and methods for the diagnosis and treatment of diseases associated with CD73-expression, e.g., cancer. Such diseases can be treated, e.g., by direct therapy with the anti-CD73 binding molecules disclosed herein (e.g., naked antibodies or antibody-drug conjugates that bind CD73), by adjuvant therapy with other antigen-binding anticancer agents such as immune checkpoint inhibitors (e.g., anti-CTLA-4 and anti-PD-1 monoclonal antibodies), and/or by combination therapies where the anti-CD73 molecules are administered before, after, or concurrently with chemotherapy.

Wikipedia References

Li Cheng Photo 7

Li Cheng

Work:

His ancestral lineage was with the Tang Dynasty imperial family, the Li ( 李 ) family,
His works include “Jigger ", " Joy in Fishing ", " Cold crow ", and " Landscape ".

Education:
Area of science:

Painting

Specialty:

Painter

Skills & Activities:
Activity:

Fishing

Control profile
Li Y Cheng from Columbia, MO, age ~56 Get Report